Geneviève Rodier

1.6k total citations
26 papers, 1.3k citations indexed

About

Geneviève Rodier is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Geneviève Rodier has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Geneviève Rodier's work include Cancer-related Molecular Pathways (9 papers), DNA Repair Mechanisms (6 papers) and Ubiquitin and proteasome pathways (6 papers). Geneviève Rodier is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), DNA Repair Mechanisms (6 papers) and Ubiquitin and proteasome pathways (6 papers). Geneviève Rodier collaborates with scholars based in France, Canada and Japan. Geneviève Rodier's co-authors include Philippe Coulombe, Sylvain Meloche, Claude Sardet, Pierre‐Luc Tanguay, Sylvain Meloche, Matthieu Lacroix, S. William Pelletier, Éric Bonneil, Christel Boutonnet and Selma El Messaoudi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Cell Biology.

In The Last Decade

Geneviève Rodier

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geneviève Rodier France 16 1.1k 419 325 199 121 26 1.3k
Muling Mao United States 14 1.3k 1.3× 501 1.2× 222 0.7× 227 1.1× 167 1.4× 16 1.7k
Robert F. Shearer Australia 15 925 0.9× 393 0.9× 406 1.2× 159 0.8× 93 0.8× 18 1.3k
Xiao‐Dan Ji China 15 847 0.8× 241 0.6× 214 0.7× 220 1.1× 68 0.6× 19 1.1k
John J. Upson United States 10 1.2k 1.1× 335 0.8× 190 0.6× 378 1.9× 147 1.2× 11 1.5k
Melanie Braig Germany 15 1.3k 1.2× 450 1.1× 197 0.6× 115 0.6× 258 2.1× 22 1.8k
Mahesh Saqcena United States 18 661 0.6× 269 0.6× 199 0.6× 117 0.6× 85 0.7× 22 1.1k
Jonathan Hurov United States 15 847 0.8× 159 0.4× 256 0.8× 340 1.7× 85 0.7× 17 1.3k
Fatih Ceteci Germany 14 923 0.9× 413 1.0× 503 1.5× 90 0.5× 151 1.2× 17 1.4k
Katrin Meissl Austria 15 1.1k 1.1× 431 1.0× 305 0.9× 391 2.0× 316 2.6× 21 1.7k
Astrid Eder United States 14 1.3k 1.2× 259 0.6× 233 0.7× 293 1.5× 308 2.5× 17 1.6k

Countries citing papers authored by Geneviève Rodier

Since Specialization
Citations

This map shows the geographic impact of Geneviève Rodier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geneviève Rodier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geneviève Rodier more than expected).

Fields of papers citing papers by Geneviève Rodier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geneviève Rodier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geneviève Rodier. The network helps show where Geneviève Rodier may publish in the future.

Co-authorship network of co-authors of Geneviève Rodier

This figure shows the co-authorship network connecting the top 25 collaborators of Geneviève Rodier. A scholar is included among the top collaborators of Geneviève Rodier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geneviève Rodier. Geneviève Rodier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velázquez, Carolina, Béatrice Orsetti, Geneviève Rodier, et al.. (2025). Replication-Poison Treatment in BRCA1 -Deficient Breast Cancer Causes MRE11 Over-Resection That Induces Single-Stranded DNA Accumulation and Mitotic Catastrophe. Cancer Research. 85(8). 1410–1423.
2.
Velázquez, Carolina, Geneviève Rodier, Béatrice Orsetti, et al.. (2024). CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in BRCA1-WT and olaparib resistant in Triple Negative Breast Cancer. Cancer Letters. 589. 216820–216820. 10 indexed citations
3.
Houlès, Thibault, Olivier Kirsh, Stanislas du Manoir, et al.. (2022). Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 23(16). 9217–9217. 3 indexed citations
4.
Lacroix, Matthieu, Geneviève Rodier, Olivier Kirsh, et al.. (2016). E4F1 controls a transcriptional program essential for pyruvate dehydrogenase activity. Proceedings of the National Academy of Sciences. 113(39). 10998–11003. 25 indexed citations
5.
Rodier, Geneviève, Olivier Kirsh, Martín A. Baraibar, et al.. (2015). The Transcription Factor E4F1 Coordinates CHK1-Dependent Checkpoint and Mitochondrial Functions. Cell Reports. 11(2). 220–233. 33 indexed citations
6.
Houlès, Thibault, Geneviève Rodier, Laurent Le Cam, Claude Sardet, & Olivier Kirsh. (2015). Description of an optimized ChIP-seq analysis pipeline dedicated to genome wide identification of E4F1 binding sites in primary and transformed MEFs. Genomics Data. 5. 368–370. 7 indexed citations
7.
Hatchi, Elodie, Geneviève Rodier, Matthieu Lacroix, et al.. (2011). E4F1 deficiency results in oxidative stress–mediated cell death of leukemic cells. The Journal of Experimental Medicine. 208(7). 1403–1417. 18 indexed citations
8.
Hatchi, Elodie, Geneviève Rodier, Claude Sardet, & Laurent Le Cam. (2011). E4F1 dysfunction results in autophagic cell death in myeloid leukemic cells. Autophagy. 7(12). 1566–1567. 9 indexed citations
9.
Fritz, Vanessa, Zohra Benfodda, Geneviève Rodier, et al.. (2010). Abrogation of De novo Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice. Molecular Cancer Therapeutics. 9(6). 1740–1754. 231 indexed citations
10.
Boutonnet, Christel, Pierre‐Luc Tanguay, Catherine Julien, et al.. (2010). Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and subcellular localization of Skp2. Cell Cycle. 9(5). 975–979. 21 indexed citations
11.
Rodier, Geneviève, Philippe Coulombe, Pierre‐Luc Tanguay, Christel Boutonnet, & Sylvain Meloche. (2008). Phosphorylation of Skp2 regulated by CDK2 and Cdc14B protects it from degradation by APCCdh1 in G1 phase. The EMBO Journal. 27(4). 679–691. 88 indexed citations
12.
Déléris, Paul, Justine Rousseau, Philippe Coulombe, et al.. (2008). Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5. Journal of Cellular Physiology. 217(3). 778–788. 65 indexed citations
13.
Lacroix, Matthieu, et al.. (2008). The histone‐binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5. EMBO Reports. 9(5). 452–458. 109 indexed citations
14.
Gravel, Simon‐Pierre, Jean-François Clément, Geneviève Rodier, et al.. (2006). Involvement of the IκB Kinase (IKK)-Related Kinases Tank-Binding Kinase 1/IKKi and Cullin-Based Ubiquitin Ligases in IFN Regulatory Factor-3 Degradation. The Journal of Immunology. 177(8). 5059–5067. 76 indexed citations
15.
Rodier, Geneviève, Constantin Makris, Philippe Coulombe, et al.. (2005). p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2. The Journal of Cell Biology. 168(1). 55–66. 36 indexed citations
16.
Coulombe, Philippe, et al.. (2004). N-Terminal Ubiquitination of Extracellular Signal-Regulated Kinase 3 and p21 Directs Their Degradation by the Proteasome. Molecular and Cellular Biology. 24(14). 6140–6150. 114 indexed citations
17.
Rodier, Geneviève, et al.. (2003). Expression of angiotensin type II receptor downregulates Cdk4 synthesis and inhibits cell-cycle progression. Oncogene. 22(17). 2633–2642. 8 indexed citations
18.
Rodier, Geneviève. (2001). p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. The EMBO Journal. 20(23). 6672–6682. 251 indexed citations
19.
Eto, Bruno, D Pansu, Geneviève Rodier, et al.. (1998). Oxyntomodulin Reduces Hydromineral Transport Through Rat Small Intestine. Digestive Diseases and Sciences. 43(8). 1814–1823. 10 indexed citations
20.
Rodier, Geneviève, Richard Magous, T. Mochizuki, et al.. (1998). A Target Cell to Oxyntomodulin and Glicentin: The Antral Smooth Muscle Cell. Annals of the New York Academy of Sciences. 865(1). 458–462. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muling Mao Breakdown of academic impact, for papers by Robert F. Shearer Breakdown of academic impact, for papers by Xiao‐Dan Ji Breakdown of academic impact, for papers by John J. Upson Breakdown of academic impact, for papers by Melanie Braig Breakdown of academic impact, for papers by Mahesh Saqcena Breakdown of academic impact, for papers by Jonathan Hurov Breakdown of academic impact, for papers by Fatih Ceteci Breakdown of academic impact, for papers by Katrin Meissl Breakdown of academic impact, for papers by Astrid Eder
Rankless by CCL
2026